Fresenius Kabi
Clinical trials sponsored by Fresenius Kabi, explained in plain language.
-
New study checks if IV fat emulsion prevents nutrient deficiencies in Long-Term patients
Disease control Recruiting nowThis study looks at the safety of a liquid nutrition product called SMOFlipid in 100 patients (children 1 month and older, plus adults) who need IV nutrition for at least 8 weeks. The goal is to see how often patients develop a lack of essential fats or a liver problem linked to …
Phase: PHASE4 • Sponsor: Fresenius Kabi • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New study checks if IV fat emulsion is safe for kids with liver issues
Disease control Recruiting nowThis study looks at whether Omegaven, a special IV fat source, is safe for children under 18 who have liver problems caused by long-term IV feeding. About 40 kids will be monitored for signs of essential fatty acid deficiency, like dry skin or poor growth, over at least 8 weeks. …
Sponsor: Fresenius Kabi • Aim: Disease control
Last updated May 26, 2026 12:03 UTC